We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
+7.77%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+673.77%
AUM
$297B
AUM Growth
+$53.1B
Cap. Flow
+$26.9B
Cap. Flow %
9.06%
Top 10 Hldgs %
35.93%
Holding
10,215
New
1,302
Increased
3,894
Reduced
3,315
Closed
1,631

Sector Composition

Rank Sector Weight
1 Technology 3.96%
2 Consumer Discretionary 3.1%
3 Financials 1.5%
4 Healthcare 1.15%
5 Communication Services 1.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMAT
8351
CALL
DELISTED
Meta Materials Inc. Common Stock
MMAT
$9.15K ﹤0.01%
425
-2,342
-85% -$56.3K
FRXB.WS
8352
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$9.01K ﹤0.01%
60,051
XTIA icon
8353
XTI Aerospace
XTIA
$57.7M
$8.99K ﹤0.01%
+2
New +$15.1K
LTCHW
8354
DELISTED
Latch, Inc. Warrant expiring 6/4/2026
LTCHW
$8.88K ﹤0.01%
83,793
-2,849
-3% -$242
TLSA icon
8355
Tiziana Life Sciences
TLSA
$124M
$8.84K ﹤0.01%
+12,971
New +$11K
BNKK
8356
Bonk Inc
BNKK
$8.48M
$8.83K ﹤0.01%
+601
New +$8.52K
FABC
8357
Fabric.AI Inc
FABC
$17.9M
$8.6K ﹤0.01%
98
-99
-50% -$7.3K
THCPW
8358
DELISTED
Thunder Bridge Capital Partners IV, Inc. Warrant
THCPW
$8.41K ﹤0.01%
+45,340
New +$7.44K
LLAP.WS
8359
DELISTED
Terran Orbital Corporation Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
LLAP.WS
$8.22K ﹤0.01%
51,037
-1,141
-2% -$232
CATX icon
8360
Perspective Therapeutics
CATX
$339M
$8.16K ﹤0.01%
+1,222
New +$7.42K
USAS
8361
Americas Gold and Silver
USAS
$1.58B
$8.08K ﹤0.01%
9,158
-33,926
-79% -$39.6K
ABVEW
8362
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
$7.82K ﹤0.01%
97,688
-684
-0.7% -$62
PDYNW icon
8363
Palladyne AI Corp Warrants
PDYNW
$185K
$7.8K ﹤0.01%
197,345
-895
-0.5% -$65
OPA.WS
8364
DELISTED
Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
OPA.WS
$7.72K ﹤0.01%
203,577
-135
-0.1% -$7
DNA.WS
8365
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$7.59K ﹤0.01%
28,938
-749
-3% -$146
GRCE
8366
Grace Therapeutics
GRCE
$34.5M
$7.46K ﹤0.01%
+2,369
New +$7.07K
CISO
8367
CISO Global
CISO
$12.2M
$7.45K ﹤0.01%
2,790
-2,829
-50% -$9.42K
SUNL
8368
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
$7.39K ﹤0.01%
1,275
-6,838
-84% -$51.9K
FURY
8369
Fury Gold Mines
FURY
$109M
$7.34K ﹤0.01%
+17,470
New +$8.67K
ONCT
8370
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$7.33K ﹤0.01%
+1,062
New +$7K
KTTA icon
8371
Pasithea Therapeutics
KTTA
$14.8M
$7.28K ﹤0.01%
+743
New +$5.99K
NRXP icon
8372
NRX Pharmaceuticals
NRXP
$132M
$7.28K ﹤0.01%
+1,505
New +$9.05K
AEY
8373
DELISTED
ADDvantage Technologies Group
AEY
$7.24K ﹤0.01%
1,168
+102
+10% +$815
RGTIW icon
8374
Rigetti Computing Warrants
RGTIW
$150M
$7.2K ﹤0.01%
52,481
-1,716
-3% -$180
ECXWW
8375
ECARX Holdings Warrants
ECXWW
$1.08M
$7K ﹤0.01%
94,333
-1,005
-1% -$95

Similar funds

Jane Street's Q2 2023 Portfolio in Review

As of Q2 2023, Jane Street held 10,215 positions worth $297B, up 22% from $244B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Jane Street deployed $26.9B of net new capital in Q2 2023, opening 1,302 new positions and adding to 3,894 existing holdings. Its largest new stake was Kenvue: 10,291,011 shares worth $272M.

By sector, the portfolio is most concentrated in Technology at 4% of assets, up from 2.5% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $667M trimmed.

  • Jane Street's largest Q2 2023 buy was Kenvue: 10,291,011 shares worth $272M.
  • Jane Street added most to Apple in Q2 2023, an estimated $2.15B increase.
  • Jane Street's biggest Q2 2023 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $667M.
  • Jane Street fully exited JPMorgan BetaBuilders Europe ETF in Q2 2023, selling an estimated $325M.
  • Jane Street's ten largest holdings make up 36% of its $297B portfolio in Q2 2023.
  • Jane Street opened 1,302 new positions and closed 1,631 in Q2 2023.
  • Jane Street's portfolio value rose 22% quarter-over-quarter to $297B.

Based on Jane Street's 13F filing for Q2 2023, filed 14 Aug 2023.